Trial intelligence / Profile preview

Miglitol in T2D Patients Treated with Biguanide

NCT00334503Phase 3Completed

Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of miglitol in type 2 diabetes mellitus (T2DM), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.. Status: completed.

02

Drugs

miglitol
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00334503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00334503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call